Soiken Holdings Inc. (TYO:2385)
Japan · Delayed Price · Currency is JPY 215.00
+2.00 (0.94%)
Aug 6, 2026, 12:33 PM JST
Soiken Holdings Market Cap
Soiken Holdings has a market cap or net worth of 5.57 billion as of August 5, 2026. Its market cap has increased by 29.09% in one year.
Market Cap
5.57B
Enterprise Value
-71.30M
Revenue
4.40B
Ranking
n/a
PE Ratio
30.28
Stock Price
215.00
ChartMarket Cap Chart
Since December 19, 2003, Soiken Holdings's market cap has decreased from 71.34B to 5.57B, a decrease of -92.19%. That is a compound annual growth rate of -10.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 5.57B | -9.36% |
| Dec 30, 2025 | 6.15B | 97.48% |
| Dec 30, 2024 | 3.11B | -29.17% |
| Dec 29, 2023 | 4.39B | -39.13% |
| Dec 30, 2022 | 7.22B | -12.93% |
| Dec 30, 2021 | 8.29B | -49.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.04B |
| Carna Biosciences | 6.32B |
| CellSource | 6.11B |
| Noile-Immune Biotech | 6.03B |
| Chordia Therapeutics | 6.03B |
| PRISM BioLab Co.,LTD | 6.03B |
| Chiome Bioscience | 5.52B |
| Cyfuse Biomedical K.K. | 5.20B |